| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 1.0 | Recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | intrahepatic cholangiocarcinoma | NEDD8 activating enzyme inhibitor | 2.0 | Suspended | ClinicalTrials |
| PEVONEDISTAT | Small molecule | myelodysplastic syndrome | NEDD8 activating enzyme inhibitor | 1.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | metastatic melanoma | NEDD8 activating enzyme inhibitor | 1.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | NEDD8 activating enzyme inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | neoplasm | NEDD8 activating enzyme inhibitor | 1.0 | Terminated | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 2.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | non-small cell lung carcinoma | NEDD8 activating enzyme inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 2.0 | Terminated | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| PEVONEDISTAT | Small molecule | chronic myelomonocytic leukemia | NEDD8 activating enzyme inhibitor | 2.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | neoplasm | NEDD8 activating enzyme inhibitor | 1.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | non-small cell lung carcinoma | NEDD8 activating enzyme inhibitor | 2.0 | Terminated | ClinicalTrials |
| PEVONEDISTAT | Small molecule | myelodysplastic syndrome | NEDD8 activating enzyme inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute lymphoblastic leukemia | NEDD8 activating enzyme inhibitor | 1.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | cancer | NEDD8 activating enzyme inhibitor | 1.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | acute myeloid leukemia | NEDD8 activating enzyme inhibitor | 1.0 | Completed | ClinicalTrials |
| PEVONEDISTAT | Small molecule | mesothelioma | NEDD8 activating enzyme inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | hepatocellular carcinoma | NEDD8 activating enzyme inhibitor | 2.0 | Suspended | ClinicalTrials |
| PEVONEDISTAT | Small molecule | multiple myeloma | NEDD8 activating enzyme inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | diffuse large B-cell lymphoma | NEDD8 activating enzyme inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| PEVONEDISTAT | Small molecule | myelodysplastic syndrome | NEDD8 activating enzyme inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| PEVONEDISTAT | Small molecule | myelodysplastic syndrome | NEDD8 activating enzyme inhibitor | 2.0 | Completed | ClinicalTrials |